The link between animal viruses and human health is under the spotlight. Diseases like SARS, HIV and Avian flu probably originated in animals and evolved to humans. A new flu pandemic, which many experts believe is inevitable, combined with an animal virus could have a devastating impact across the world.
Scientific experts at a British Royal Society [1] conference in London in January 2004 said there was a growing risk that more viruses will jump the species barrier and infect humans.
Influenza viruses are classified as types A, B and C.
Type A flu viruses are found in many species of animals, including ducks, chickens, pigs, whales, horses, and seals. According to the World Health Organisation the avian flu outbreak in Asia which has resulted in 20 deaths in Thailand and Vietnam are from Type A subgroup H5N1. National officials have slaughtered hundreds of thousands of chickens in an effort to stop the disease from spreading. In China, thousands of civet cats have been killed after researchers found links between the animal and new cases of SARS.
In 2003, EU veterinary experts restricted the movement of poultry and eggs from Belgium and the Netherlands throughout the Union and beyond. This followed an outbreak of avian flu in the Netherlands of the virus strand A H7N7 . A total of 30 million birds were culled, 89 cases of human related avian flu were recorded and one death. In this instance there was evidence of transmission to humans, but the main symptoms were conjunctivitis rather than more serious health problems.
The EU is to act by fast-tracking the legislation needed to create the European Centre for Disease Control (ECDC) through the Parliament and the Council, and better information exchange between Member States.
On 13 February 2004, the former Commissioner for Health, David Byrne, announced a new planning instrument, a working paper on Influenza Pandemic Preparedness and Response Planning in the Community. It will explain the stages of an influenza pandemic based on WHO definitions and set out the main objectives for action. The paper will address key issues of co-ordination and the availability of vaccines and anti-virals.
